125 related articles for article (PubMed ID: 36521793)
1. Factors Associated with Hospital Length of Stay and Adverse Events following Percutaneous Ablation of Lung Tumors.
Tahir I; Cahalane AM; Saenger JA; Leppelmann KS; Abrishami Kashani M; Marquardt JP; Silverman SG; Shyn PB; Mercaldo ND; Fintelmann FJ
J Vasc Interv Radiol; 2023 May; 34(5):759-767.e2. PubMed ID: 36521793
[TBL] [Abstract][Full Text] [Related]
2. High-Frequency Jet Ventilation Versus Spontaneous Respiration for Percutaneous Cryoablation of Lung Tumors: Comparison of Adverse Events and Procedural Efficiency.
Graur A; Mercaldo ND; Simon J; Alici C; Saenger JA; Cahalane AM; Vazquez R; Fintelmann FJ
AJR Am J Roentgenol; 2024 Apr; 222(4):e2330557. PubMed ID: 38264999
[No Abstract] [Full Text] [Related]
3. Comparison of Percutaneous Image-Guided Microwave Ablation and Cryoablation for Sarcoma Lung Metastases: A 10-Year Experience.
Bourgouin PP; Wrobel MM; Mercaldo ND; Murphy MC; Leppelmann KS; Levesque VM; Muniappan A; Silverman SG; Shepard JO; Shyn PB; Fintelmann FJ
AJR Am J Roentgenol; 2022 Mar; 218(3):494-504. PubMed ID: 34612679
[No Abstract] [Full Text] [Related]
4. Risk of persistent air leaks following percutaneous cryoablation and microwave ablation of peripheral lung tumors.
Abrishami Kashani M; Murphy MC; Saenger JA; Wrobel MM; Tahir I; Mrah S; Ringer S; Bunck AC; Silverman SG; Shyn PB; Pachamanova DA; Fintelmann FJ
Eur Radiol; 2023 Aug; 33(8):5740-5751. PubMed ID: 36892641
[TBL] [Abstract][Full Text] [Related]
5. Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
Leppelmann KS; Levesque VM; Bunck AC; Cahalane AM; Lanuti M; Silverman SG; Shyn PB; Fintelmann FJ
Ann Surg Oncol; 2021 Oct; 28(11):5829-5839. PubMed ID: 33620616
[TBL] [Abstract][Full Text] [Related]
6. Safety and Effectiveness of Percutaneous Image-Guided Thermal Ablation of Juxtacardiac Lung Tumors.
Murphy MC; Tahir I; Saenger JA; Abrishami Kashani M; Muniappan A; Levesque VM; Shyn PB; Silverman SG; Fintelmann FJ
J Vasc Interv Radiol; 2023 May; 34(5):750-758. PubMed ID: 36707028
[TBL] [Abstract][Full Text] [Related]
7. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
Fintelmann FJ; Graur A; Oueidat K; Simon J; Barnes JMH; McDermott S; Genshaft SJ; Healey TT; Suh RD; Maxwell AWP; Abtin F
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330300. PubMed ID: 37966037
[No Abstract] [Full Text] [Related]
8. Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
Wrobel MM; Bourgouin PP; Abrishami Kashani M; Leppelmann KS; Vazquez R; Pachamanova DA; Fintelmann FJ
AJR Am J Roentgenol; 2021 Nov; 217(5):1153-1163. PubMed ID: 34008999
[No Abstract] [Full Text] [Related]
9. A national analysis of the complications, cost, and mortality of percutaneous lung ablation.
Welch BT; Brinjikji W; Schmit GD; Callstrom MR; Kurup AN; Cloft HJ; Woodrum DA; Nichols FC; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):787-91. PubMed ID: 25866239
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.
Matsui Y; Hiraki T; Gobara H; Fujiwara H; Iguchi T; Shirakawa Y; Fujiwara T; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2014 Oct; 25(10):1566-72. PubMed ID: 25156828
[TBL] [Abstract][Full Text] [Related]
11. Comparison of expected imaging findings following percutaneous microwave and cryoablation of pulmonary tumors: ablation zones and thoracic lymph nodes.
Wrobel MM; Cahalane AM; Pachamanova D; Leppelmann KS; Silverman SG; Sharma A; Shyn PB; Mercaldo ND; Fintelmann FJ
Eur Radiol; 2022 Dec; 32(12):8171-8181. PubMed ID: 35704108
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Local Progression after Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation Based on a Review of 147 Tumors.
Yang Q; Qi H; Zhang R; Wan C; Song Z; Zhang L; Fan W
J Vasc Interv Radiol; 2017 Apr; 28(4):481-489. PubMed ID: 28111196
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates.
Herrera LJ; Fernando HC; Perry Y; Gooding WE; Buenaventura PO; Christie NA; Luketich JD
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):929-37. PubMed ID: 12698158
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study.
Men M; Ye X; Fan W; Zhang K; Bi J; Yang X; Zheng A; Huang G; Wei Z
Korean J Radiol; 2016; 17(6):864-873. PubMed ID: 27833402
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases.
Matsui Y; Hiraki T; Gobara H; Iguchi T; Fujiwara H; Nagasaka T; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2015 Mar; 26(3):303-10;quiz 311. PubMed ID: 25612808
[TBL] [Abstract][Full Text] [Related]
16. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases.
Gillams A; Khan Z; Osborn P; Lees W
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):724-30. PubMed ID: 23070108
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study.
Sänger JA; Graur A; Tahir I; Price MC; Keane FK; Lanuti M; Sharma A; Fintelmann FJ
Lung Cancer; 2023 Jul; 181():107231. PubMed ID: 37172368
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for lung tumors: outcomes, effects on survival, and prognostic factors.
Akhan O; Güler E; Akıncı D; Çiftçi T; Köse IÇ
Diagn Interv Radiol; 2016; 22(1):65-71. PubMed ID: 26611111
[TBL] [Abstract][Full Text] [Related]
19. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.
Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH
Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128
[TBL] [Abstract][Full Text] [Related]
20. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study.
Liu H; Steinke K
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):466-74. PubMed ID: 23870347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
